PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $297,434 | 0.0% | 62,355 | 0.0% | 0.00% | – |
| Q1 2023 | $297,434 | -82.0% | 62,355 | -67.2% | 0.00% | -100.0% |
| Q4 2022 | $1,654,610 | -99.9% | 190,185 | +6.7% | 0.00% | 0.0% |
| Q3 2022 | $2,121,581,000 | -18.8% | 178,284 | -2.8% | 0.00% | 0.0% |
| Q2 2022 | $2,614,034,000 | -26.1% | 183,441 | +7.9% | 0.00% | -50.0% |
| Q1 2022 | $3,539,067,000 | -16.2% | 169,984 | -7.1% | 0.00% | 0.0% |
| Q4 2021 | $4,225,406,000 | -23.8% | 182,918 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $5,547,628,000 | -15.3% | 186,162 | -2.9% | 0.00% | -33.3% |
| Q2 2021 | $6,546,320,000 | +2.7% | 191,637 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $6,371,714,000 | -46.8% | 193,728 | -0.6% | 0.00% | -50.0% |
| Q4 2020 | $11,983,686,000 | -3.6% | 194,825 | -44.3% | 0.01% | -14.3% |
| Q3 2020 | $12,425,001,000 | – | 350,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |